Visceral Fat Burning
Selective visceral fat reduction, metabolic improvement, GH optimization
Overview
Combines Tesamorelin (the only peptide with direct clinical evidence for visceral fat reduction in humans) with Ipamorelin to potentiate GH release. Tesamorelin is FDA-approved for HIV-associated lipodystrophy.
Peptides in this Protocol
1
2
Protocol Details
| Duration | 12-26 weeks |
| Timing | Ipamorelin morning fasted. Tesamorelin + Ipamorelin before bed (2h+ after last meal). |
Notes
Tesamorelin has Phase III clinical evidence for visceral fat reduction. Minimum duration of 12 weeks for significant results. Higher cost than other GH stacks.